• FAST Platform: Food-Grade Nanoparticles for Enhanced Nutrace

  2026-06-26

  The reference study introduces Facilitated Self-Assembling Technology (FAST) as a food-grade platform to produce stable, bioavailable nanoparticles of hydrophobic nutraceuticals without synthetic surfactants or solvents. This innovation enhances oral delivery and regulatory acceptance of compounds like curcumin and resveratrol, with evidence for improved stability, biocompatibility, and in vitro uptake.

• TBXA2R–ERM Axis Drives Metastasis in Triple-Negative Breast

  2026-06-26

  This study reveals that the thromboxane A2 receptor (TBXA2R), an overexpressed GPCR in several cancers, directly activates ERM proteins to promote motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC) cells. The findings elucidate a novel GPCR-mediated signaling axis underlying metastasis and highlight potential targets for anti-metastatic therapies.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-06-25

  Wu et al. (2021) uncover how selective autophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, precisely controls the degradation of transcription factor IRF3. This mechanism fine-tunes type I interferon production and immune suppression, offering new insights into innate antiviral defense regulation.

• 3X FLAG Peptide: Transforming Affinity Purification in Cance

  2026-06-25

  This article explores how the 3X (DYKDDDDK) Peptide advances translational research, particularly in cancer metabolism, by enabling ultrasensitive affinity purification and detection of recombinant proteins. Drawing insights from recent studies on metabolic reprogramming in triple-negative breast cancer and integrating best practices, we provide strategic guidance for researchers seeking to bridge mechanistic discovery and practical innovation.

• SmD2 Acetylation Modulates PARP Inhibitor Sensitivity in HCC

  2026-06-24

  This study reveals that acetylation-dependent regulation of the spliceosome core component SmD2 impacts alternative splicing in hepatocellular carcinoma (HCC), influencing DNA damage repair and sensitivity to PARP inhibitors. The findings highlight novel therapeutic avenues for HCC by targeting SmD2 and its regulatory pathways, particularly in combination with PARP inhibition.

• Protease Inhibitor Cocktail (100X in DMSO, EDTA plus): Preci

  2026-06-23

  Explore how the Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) delivers comprehensive protein degradation prevention in complex assays. Uncover its advanced mechanism, unique advantages, and its critical role in epitranscriptomic studies targeting the HSP90-METTL3 axis.

• Tofacitinib Citrate (CP-690550): Mechanisms and Assay Implic

  2026-06-23

  Explore the mechanisms and nuanced assay implications of Tofacitinib citrate (CP-690550 citrate) in immune regulation and inflammatory disorder research. This article uniquely analyzes recent vascular findings, enabling researchers to optimize experimental design and interpret results with greater precision.

• Translocon Remodeling During Protein Synthesis at the ER: In

  2026-06-22

  This study leverages selective ribosome profiling to map how accessory factors dynamically remodel the endoplasmic reticulum (ER) translocon during cotranslational synthesis of secretory and multipass membrane proteins. The findings reveal substrate-driven assembly and disassembly of complexes like OST-A, GEL, PAT, and BOS, clarifying mechanisms underlying efficient protein maturation.

• X-press Tag Peptide: Optimizing N-terminal Leader for Purifi

  2026-06-22

  X-press Tag Peptide empowers precise protein purification and detection, streamlining workflows for recombinant protein studies and post-translational modification research. Its advanced design, solubility, and compatibility with key affinity platforms offer tangible advantages for bench scientists seeking high-fidelity results.

• TBXA2R-ERM Axis Drives Motility and Metastasis in TNBC Cells

  2026-06-21

  A recent study elucidates how the thromboxane A2 receptor (TBXA2R), a GPCR, activates ezrin, radixin, and moesin (ERM) proteins to drive cell motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC). By mapping this pathway, the research highlights new molecular targets for anti-metastatic strategies and deepens our understanding of GPCR signaling in cancer progression.

• ETS1 Modulates Mitophagy to Ameliorate Lung Injury in BPD Mo

  2026-06-20

  This study identifies ETS1 as a critical regulator that protects against bronchopulmonary dysplasia (BPD) by targeting the SENP2/HSPA8/FUNDC1 axis to suppress mitochondrial damage-induced autophagy. The findings highlight a mechanistic pathway underlying BPD pathogenesis and suggest potential therapeutic strategies centered on mitophagy modulation.

• OTUD7B Modulates SQSTM1 and IRF3 to Regulate Antiviral Immun

  2026-06-19

  The reference study uncovers OTUD7B as a critical deubiquitinase that regulates antiviral immunity by targeting the autophagy receptor SQSTM1/p62, thereby promoting selective degradation of IRF3. This mechanistic insight enhances our understanding of host antiviral responses and suggests potential approaches for modulating innate immunity.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Localization

  2026-06-19

  ARCA Cy5 EGFP mRNA (5-moUTP) from APExBIO enables highly quantitative, immune-silent mRNA delivery and localization studies in mammalian cells. Its advanced modifications—ARCA capping and 5-methoxyuridine nucleotides—translate into robust fluorescence-based workflows with reduced innate immune activation, setting a new benchmark for transfection efficiency analysis.

• Aztreonam: Applied Workflows for Gram-Negative Resistance Re

  2026-06-18

  Aztreonam, a synthetic monocyclic β-lactam antibiotic, enables precise modeling of Gram-negative bacterial resistance and its effects on cellular and hepatic systems. This article unpacks experimental workflows, protocol enhancements, and troubleshooting insights for maximizing the compound’s utility in advanced microbiological and pharmacological research.

• PEG-Lipid Selection Dominates LNP Performance in mRNA Delive

  2026-06-18

  This study establishes that PEG-lipid chain length, despite representing a minor fraction of LNP composition, is a decisive factor for both in vitro and in vivo mRNA delivery efficacy. The findings have direct implications for optimizing lipid nanoparticle formulations for gene expression studies and therapeutic applications.

16825 records 1/1122 page Next 12345 下5页 Last page